US Edition
Published • loading... • Updated
Vitti Labs Prevails in Lawsuit Against FDA Over "Minimal Manipulation" Criteria for Section 361 HCT/Ps - The Morning Sun
Summary by Morning Sun
2 Articles
2 Articles
Vitti Labs Prevails in Lawsuit Against FDA Over "Minimal Manipulation" Criteria for Section 361 HCT/Ps - The Morning Sun
US District Court decision stands to benefit manufacturers of low-risk human tissue productsLIBERTY, Mo., March 27, 2026 /PRNewswire/ -- Vitti Labs (or "the Company") announced today that U.S. District Court Judge Brian C. Wimes granted the Company's motion for summary judgment in its lawsuit against the Food and Drug Administration (FDA) over the correct standard for determining whether human tissue products qualify for regulation under a low-r…
·Pittsburg, United States
Read Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
